Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 273, Issue 6 42-6, 1997, Pages

  Mönnikes, Hubert ^a   Lauer, Gerd ^a   Bauer, Christoph ^a   Tebbe, Johannes ^a   Zittel, Tillmann T ^a,b   Arnold, Rudolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Area postrema; Brain gut axis; Cholecystokinin; Feeding; Functional gastrointestinal disorders; Gastrointestinal function; Nucleus of the solitary tract

Indexed keywords

CAPSAICIN; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; LIPID; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; CONTROLLED STUDY; FAT INTAKE; GENE EXPRESSION; LOCUS CERULEUS; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS; STOMACH MOTILITY; THALAMUS MIDLINE NUCLEUS; VAGUS NERVE DORSAL NUCLEUS;

EID: 0031414267     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1997.273.6.r2059     Document Type: Article

References (18)

1. Baile, C. A., C. L. McLaughlin, and M. A. Della-Fera. Role of cholecystokinin and opioid peptides in control of food intake. Physlol. Rev. 66: 172-235, 1986.
2. Bonham, A. C., and E. M. Hasser. Area postrema and aortic or vagal afferents converge to excite cells in nucleus tractus solitarius. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1674-H1685, 1993.
3. Bradwejn, J., D. Koszycki, and R. Payeur. Role of cholecystokinin in irritable bowel syndrome. Am. J. Psychiatry 148: 277, 1991.
4. Butler, P. D., J. M. Weiss, J. C. Stout, and C. B. Nemeroff. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J. Neurosci. 10: 176-183, 1990.
5. Cedarbaum, J. M., and G. K. Aghajanian. Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neural. 178: 1-16, 1978.
6. Chen, D. Y., J. A. Deutsch, M. F. Gonzalez, and Y. Gu. The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718. Neurosci. Lett. 149: 91-94, 1993.
7. Corp, E. S., J. McQuade, T. H. Moran, and G. P. Smith. Characterization of type A and type B receptor binding sites in rat vagus nerve. Brain Res. 623: 161-166, 1993.
8. Crawley, J. N., S. E. Hays, and S. M. Paul. Vagotomy abolishes the inhibitory effects of cholecystokinin on rat exploratory behaviors. Eur. J. Pharmacol. 73: 370-380, 1981.
9. Fraser, K. A., and J. S. Davison. Cholecystokinin-induced c-fos expression in the rat brain stem is influenced by vagal nerve integrity. Exp. Physiol. 77: 225-228, 1992.
10. Fraser, K. A., and J. S. Davison. Meal-induced c-fos expression in brain stem is not dependent on cholecystokinin release. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R235-R239, 1993.
11. Fräser, K. A., E. Raizada, and J. S. Davison. Oral-pharyngealesophageal and gastric cues contribute to meal-induced c-fos expression. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R223-R230, 1995.
12. Hill, D. R., N. J. Campbell, T. M. Shaw, and G. N. Woodruft. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective non-peptide CCK antagonists. J. Neurosci. 7: 2967-2976, 1987.
13. Hoffman, G. E., M. S. Smith, and J. G. Verbalis. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front. Neuroendocrinol. 14: 173-213, 1993.
14. Jensen, R. T., and J. D. Gardner. Cholecystokinin receptor antagonists in vitro. In: Cholecystokinin Antagonists in Gastroenterology, edited by G. Adler and C. Beglinger. Berlin: Springer-Verlag, 1991, p. 93-111.
15. Kawano, H., and S. Masuko. Neurons in the caudal ventrolateral medulla projecting to the paraventricular hypothalamic nucleus receive synaptic inputs from the nucleus of the solitary tract: a light and electron microscopic double-labeling study in the rat. Neurosci. Lett. 218: 33-36, 1997.
16. Kohn, D. F., and S. W. Barthold. Biology and diseases of rats. In: Laboratory Animal Medicine, edited by J. G. Fox, B. J. Cohen, and F. M. Loew. Orlando, FL: Academic, 1984, p. 91-122.
17. Koop, H., H. Mönnikes, I. Koop, J. Dionysius, C. Schwarz, and R. Arnold. Effect of the prokinetic drug cisapride on gastrointestinal hormone release. Scand. J. Gastroenterol. 8: 907-913, 1986.
18. Lloyd, K. C. K., H. H. Hölzer, T. T. Zittel, and H. E. Raybould. Duodenal lipid inhibits gastric acid secretion by vagal, capsaicin-sensitive afferent pathways in rats. Am. J. Physiol, 264 (Gastrointest. Liver Physiol. 27): G659-G663, 1993.